Form 8-K - Current report:
SEC Accession No. 0001193125-13-041209
Filing Date
2013-02-06
Accepted
2013-02-06 16:39:25
Documents
3
Period of Report
2013-02-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d482073d8k.htm 8-K 14910
2 PRESS RELEASE d482073dex991.htm EX-99.1 13440
3 GRAPHIC g482073g97v11.jpg GRAPHIC 26553
  Complete submission text file 0001193125-13-041209.txt   66367
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 13578351
SIC: 2835 In Vitro & In Vivo Diagnostic Substances